Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug
ConclusionOur results on the antitumor effects of ivermectin support its clinical testing.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Drugs & Pharmacology | Ovarian Cancer | Ovaries | Prostate Cancer | Stem Cell Therapy | Stem Cells | Study | Tamoxifen | Taxotere